aap is a medical technology company that develops, manufactures and markets biomaterials and implants for the areas Ortho/Trauma/Spine. Its product portfolio includes bone cements, bone graft substitutes, antibiotic carriers, and implants for fracture healing and joint replacement.

In addition to its headquarters the company has sites in Dieburg and Obernburg near Frankfurt am Main and Nijmegen in the Netherlands.

aap Implantate AG stock has been listed in the Prime Standard segment of the Frankfurt Stock Exchange since May 16, 2003.